Dipropylacetate (Dépakine, Ergenyl) in the treatment of epilepsy.
D000293:Adolescent; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001463:Barbiturates / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004357:Drug Synergism; D004569:Electroencephalography; D004827:Epilepsy / Q000188:drug therapy*; D004832:Epilepsy, Absence / Q000188:drug therapy; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009207:Myoclonus / Q000188:drug therapy; D011324:Primidone / Q000627:therapeutic use; D014631:Valerates / Q000627:therapeutic use*
D000927:Anticonvulsants; D001463:Barbiturates; D014631:Valerates; D011324:Primidone